Skip to main content

Loading market data...

JNJ

Johnson & Johnson

NYSE • United states

$255.99

-$3.37

(-1.30%)

Source: Yahoo Finance · Quote time Oct 21, 2026 16:47 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Johnson & Johnson (JNJ)

Unavailable

Quotes may be delayed

$616.91B

Market Cap

2,049,789

Volume

29.3

P/E Ratio

2.06%

Div Yield

Johnson & Johnson Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

21 Oct 2026

Johnson & Johnson filed Form 10-Q

Johnson & Johnson submitted Form 10-Q to the SEC for the period ending Sep 27, 2026.

13 Oct 2026

Johnson & Johnson reported Operating or financial results

Johnson & Johnson filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

4 Aug 2026

Johnson & Johnson reported A director or senior management change or compensation event

Johnson & Johnson filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.

30 Jul 2026

Johnson & Johnson reported Regulation FD disclosure

Johnson & Johnson filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

28 Jul 2026

Johnson & Johnson reported Regulation FD disclosure

Johnson & Johnson filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$20.42B

Total assets (USD)$201.06B

Total liabilities (USD)$116.09B

Shareholders' equity (USD)$84.97B

Long-term debt (USD)$37.34B

Debt due within a year (USD)$2.00B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 28 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B
PM - Philip Morris International Inc.	$197.46 Yahoo Finance	$307.76B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$25.31B	Unavailable	$5.53B	$2.27	10-Q · 23 Jul 2026
Q1 2026	$24.06B	Unavailable	$5.24B	$2.14	10-Q · 22 Apr 2026
Q4 2025	$24.56B	Unavailable	$5.12B	Unavailable	10-K · 11 Feb 2026
Q3 2025	$23.99B	Unavailable	$5.15B	$2.12	10-Q · 22 Oct 2025
Q2 2025	$23.74B	Unavailable	$5.54B	$2.29	10-Q · 24 Jul 2025
Q1 2025	$21.89B	Unavailable	$11.00B	$4.54	10-Q · 23 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $278.78

8.9% upside potential

📈

Strong Buy

Unavailable

👍

Buy

12

⏸️

Hold

6

📉

Sell

1

19 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 16:47 UTC Targets range 110.00–320.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

2

Sep 2026

Schmid Timothy

EVP, WW Chair, MedTech

Option exercise

$144.99 per share

33,597 shares

2

Sep 2026

Schmid Timothy

EVP, WW Chair, MedTech

Open-market sale

$274.74 per share

33,597 shares

17

Aug 2026

Taubert Jennifer L

EVP, WWC. Innovative Medicine

Option exercise

$115.67 per share

15,000 shares

17

Aug 2026

Taubert Jennifer L

EVP, WWC. Innovative Medicine

Open-market sale

$263.36 per share

15,000 shares

13

Aug 2026

Duato Joaquin

Director, CEO and Chairman of the Board

Option exercise

$115.67 per share

123,291 shares

13

Aug 2026

Duato Joaquin

Director, CEO and Chairman of the Board

Open-market sale

$261.17 per share

123,291 shares

6

Aug 2026

Forminard Elizabeth

EVP, Chief Legal Officer

Option exercise

$131.94 per share

9,344 shares

6

Aug 2026

Forminard Elizabeth

EVP, Chief Legal Officer

Open-market sale

$257.00 per share

15,918 shares

5

Aug 2026

Duato Joaquin

Director, CEO and Chairman of the Board

Open-market sale

$258.15 per share

48,480 shares

Top Shareholders

Vanguard Group Inc

240,349,660 shares

1.577% change

12/31/2025

Blackrock, Inc.

212,098,264 shares

-0.603% change

6/30/2026

Vanguard Capital Management Llc

157,226,374 shares

0.397% change

6/30/2026

State Street Corp

133,776,025 shares

0.225% change

6/30/2026

Vanguard Portfolio Management Llc

64,370,816 shares

1.348% change

6/30/2026

Geode Capital Management, Llc

59,086,417 shares

-0.133% change

6/30/2026

Jpmorgan Chase & Co

58,301,609 shares

-7.599% change

6/30/2026

Morgan Stanley

44,808,254 shares

0.195% change

6/30/2026

Norges Bank

31,825,084 shares

-4.886% change

6/30/2026

State Farm Mutual Automobile Insurance Co

31,590,952 shares

0% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 16:47 UTC· 13 hours ago

Research coverage and investment tools

Johnson & Johnson (JNJ) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its last price was US$255.99 on 21 Oct 2026. That is 74% of the way from its 52-week low of US$184.66 to its 52-week high of US$281.07. It paid US$5.28 a share in dividends over the last 12 months, a dividend yield of 2.06%. The latest ex-dividend date on file is 25 Aug 2026. Its market capitalisation was US$616.91 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$25.31B	Unavailable	$5.53B	$2.27	68.2%	—	—	10-Q · 23 Jul 2026 (opens in a new tab)
Q1 2026	$24.06B	Unavailable	$5.24B	$2.14	66.3%	—	$1.47B	10-Q · 22 Apr 2026 (opens in a new tab)
Q4 2025	$24.56B	Unavailable	$5.12B	Unavailable	67.6%	—	—	10-K · 11 Feb 2026 (opens in a new tab)
Q3 2025	$23.99B	Unavailable	$5.15B	$2.12	69.6%	—	—	10-Q · 22 Oct 2025 (opens in a new tab)
Q2 2025	$23.74B	Unavailable	$5.54B	$2.29	67.9%	—	—	10-Q · 24 Jul 2025 (opens in a new tab)
Q1 2025	$21.89B	Unavailable	$11.00B	$4.54	66.4%	—	$3.38B	10-Q · 23 Apr 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Sep 2026	10/13/2026	$2.59	$2.53	+2.4%
Jun 2026	7/15/2026	$2.90	$2.84	+2.1%
Mar 2026	4/14/2026	$2.70	$2.67	+1.1%
Dec 2025	1/21/2026	$2.46	$2.43	+1.2%

Cash and equivalents: $20.42B
Total assets: $201.06B
Total liabilities: $116.09B
Shareholders' equity: $84.97B
Long-term debt: $37.34B
Debt due within a year: $2.00B

10-Q · 21 Oct 2026

Johnson & Johnson filed Form 10-Q (opens in a new tab)

Johnson & Johnson submitted Form 10-Q to the SEC for the period ending Sep 27, 2026.
8-K · 13 Oct 2026

Johnson & Johnson reported Operating or financial results (opens in a new tab)

Johnson & Johnson filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 4 Aug 2026 · Management change

Johnson & Johnson reported A director or senior management change or compensation event (opens in a new tab)

Johnson & Johnson filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.
8-K · 30 Jul 2026

Johnson & Johnson reported Regulation FD disclosure (opens in a new tab)

Johnson & Johnson filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 28 Jul 2026

Johnson & Johnson reported Regulation FD disclosure (opens in a new tab)

Johnson & Johnson filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
Schmid Timothy EVP, WW Chair, MedTech	2 Sep 2026	Option exercise (M)	+33,597	$144.99	Form 4 (opens in a new tab)
Schmid Timothy EVP, WW Chair, MedTech	2 Sep 2026	Open-market sale (S)	−33,597	$274.74	Form 4 (opens in a new tab)
Taubert Jennifer L EVP, WWC. Innovative Medicine	17 Aug 2026	Option exercise (M)	+15,000	$115.67	Form 4 (opens in a new tab)
Taubert Jennifer L EVP, WWC. Innovative Medicine	17 Aug 2026	Open-market sale (S)	−15,000	$263.36	Form 4 (opens in a new tab)
Duato Joaquin Director, CEO and Chairman of the Board	13 Aug 2026	Option exercise (M)	+123,291	$115.67	Form 4 (opens in a new tab)
Duato Joaquin Director, CEO and Chairman of the Board	13 Aug 2026	Open-market sale (S)	−123,291	$261.17	Form 4 (opens in a new tab)
Forminard Elizabeth EVP, Chief Legal Officer	6 Aug 2026	Option exercise (M)	+9,344	$131.94	Form 4 (opens in a new tab)
Forminard Elizabeth EVP, Chief Legal Officer	6 Aug 2026	Open-market sale (S)	−15,918	$257.00	Form 4 (opens in a new tab)
Duato Joaquin Director, CEO and Chairman of the Board	5 Aug 2026	Open-market sale (S)	−48,480	$258.15	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	240,349,660	1.577%
Blackrock, Inc.	6/30/2026	212,098,264	-0.603%
Vanguard Capital Management Llc	6/30/2026	157,226,374	0.397%
State Street Corp	6/30/2026	133,776,025	0.225%
Vanguard Portfolio Management Llc	6/30/2026	64,370,816	1.348%
Geode Capital Management, Llc	6/30/2026	59,086,417	-0.133%
Jpmorgan Chase & Co	6/30/2026	58,301,609	-7.599%
Morgan Stanley	6/30/2026	44,808,254	0.195%
Norges Bank	6/30/2026	31,825,084	-4.886%
State Farm Mutual Automobile Insurance Co	6/30/2026	31,590,952	0%

Previous close: 259.36 USD
Day range: 254.56 – 257.75 USD
52-week range: 184.66 – 281.07 USD
Volume: 2,049,789
Market cap: $616.91B
Average volume: 6,429,776
P/E ratio: 29.3
EPS (FY 2025, diluted): 11.03 USD
Dividends (last 12 months): 5.28 USD
Dividend yield: 2.06%
Ex-dividend date: 25 Aug 2026
Shares outstanding: 2.41B
Beta (5Y monthly): 0.22

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 16:47 UTC· 13 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:11 UTC· 21 minutes ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:11 UTC· 21 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for JNJ yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.